Preliminary Schedule

• Fri, Feb 28
• Sat, Feb 29
• Sun, Mar 1

Friday, February 28, 2020

• 07:15 08:00

  Registration/ Inscription

  (Breakfast/Petit Déjeuner)
• 08:00 08:15

  Welcome and Introductions | Mot de Bienvenue

  Dr. Naglaa Shoukry (Chair of the Canadian Network for Hepatitis C) | Université de Montréal
  Dr. Curtis Cooper (Symposium Chair) | The Ottawa Hospital Research Institute
  Dr. Angela Crawley (Symposium Co-Chair) | The Ottawa Hospital Research Institute

• 08:15 09:15

  Biomedical Research ‑ HCV Vaccine Development and Related Studies

  Dr. Seung-Hwan Lee (Co-Chair) | University of Ottawa 
  Dr. Joyce Wilson (Co-Chair) | University of Saskatchewan
  CanHepC trainees introducing Plenary Speakers  
  
  8:15 - 8:35 | Session - Dr. Ellie Barnes | Oxford University, UK
  8:35 - 8:55 | Session - Dr. John Law | University of Alberta, Canada
  8:55 - 9:15 | Questions/Panel Discussion 

• 09:15 09:45

  Oral Presentations

  9:15 - 9:30 | Oral Abstract 1 | Differential gene expression of circulating CD8 T cells of cirrhotic HCV-infected individuals identifies pathways associated with lasting dysfunction | Dr. Angela M. Crawley | Ottawa Hospital Research Institute
  
  9:30 - 9:45 | Oral Abstract 2 | The Effect of Apoptosis and Inflammasome-Mediated Pyroptosis on HCV Infection | Hannah Louise Wallace | Memorial University

• 09:45 10:00

  Coffee Break | Pause Café and Poster Browsing

• 10:00 11:00

  Social, Cultural, Environmental, and Population Health Research – HCV in Underserved Populations: Modeling and Real‑Life Data to Inform Strategies

  Dr. Julie Bruneau (Co-Chair) | Université de Montréal
  Dr. Nadine Kronfi (Co-Chair) | McGill University
  CanHepC trainees introducing Plenary Speakers 
  
  
  10:00 - 10:20 | Session: Tackling HCV transmission among people who inject drugs: insights from modeling - Dr. Natasha Martin | University of California San Diego, USA
  
  10:20 - 10:40 | Session - Dr. Nadine Kronfi | McGill University
  
  10:40 - 11:00 | Questions/Panel Discussion 

• 11:00 11:30

  Oral Presentations

  11:00 - 11:15 | Oral Abstract 1 | Effect of Sustained Virologic Response and Opioid Agonist Therapy on Mortality Among People Living with Chronic Hepatitis C | Dr. Prince Adu | University of British Columbia
  
  11:15 - 11:30 | Oral Abstract 2 | Community and Corrections Based Point-of-Care Testing into a Provincial Hepatitis C Elimination Framework | Dr. Lisa Barrett | Dalhousie University

• 11:30 12:30

  Community Session ‑ “Connecting With Care” Videos and Panel Discussion

  Dr. Curtis Cooper (Co-Chair) | The Ottawa Hospital Research Institute
  Dr. Angela Crawley (Co-Chair) | The Ottawa Hospital Research Institute
  Melisa Dickie (Chair) | CATIE

• 12:30 14:00

  Lunch and Poster Session | Présentation des Affiches

  13:00 - 13:45 | CanHepC evaluation of poster

• 14:00 14:55

  Clinical Research ‑ Hepatitis C Infection in Pregnancy & Children

  Dr. Eve Roberts (Co-Chair) | Dalhousie University
  Dr. Hugo Soudeyns (Co-Chair) | Université de Montréal
  CanHepC trainees introducing Plenary Speakers 
  
  14:00 - 14:20 | DAA use in Pregnancy - Dr. Robert Honegger | Nationwide Children's, USA
  14:20 - 14:40 | Pediatric Perspectives on DDA Use - Dr. Simon Ling | University of Toronto, Canada
  14:40 - 14:55 | Questions/Panel Discussion

• 14:55 15:25

  Oral Presentations

  14:55 - 15:10 | Oral Abstract 1 | Efficacy of Sofosbuvir/Velpatasvir (S/V): Impact of Treatment Adherence | Dr. Tianna Magel | Vancouver Infectious Diseases Centre, Vancouver, Canada
  
  15:10 - 15:25 | Oral Abstract 2 | Reinfection Following Successful Direct-Acting Antiviral Therapy for Hepatitis C Infection Among People Who Inject Drugs | Dr. Evan Cunningham | The Kirby Institute, UNSW, Sydney, Australia

• 15:25 16:00

  Health Services Research – Blueprint Update and Implementation

  Dr. Curtis Cooper (Co-Chair) | The Ottawa Hospital Research Institute
  Dr. Angela Crawley (Co-Chair) | The Ottawa Hospital Research Institute
  CanHepC trainees introducing Plenary Speakers 
  
  15:25 - 15:45 | Panel Lead - Dr. Jordan Feld | University of Toronto
  15:45 - 16:00 | Questions/Panel Discussion

• 15:45 16:00

  Coffee Break

• 16:00 16:30

  Oral Presentations

  16:00 - 16:15 | Oral Abstract 1 | HBV-HCV Co Infection Among Immigrants in Ontario, Canada |Abdool S. Yasseen | University of Toronto, Canada
  
  16:15 - 16:30 | Oral Abstract 2 | The Health Burden of Hepatitis C Infection Facing the First Nations Population in Ontario: A Province-Wide Descriptive Analysis | Andrew Mendlowitz | University of Toronto, Canada

• 16:30 16:40

  CanHepC Trainee Awards Ceremony

• 16:40 16:45

  CanHepC Symposium Closing Remarks

  Dr. Curtis Cooper | The Ottawa Hospital Research Institute
  Dr. Angela Crawley | The Ottawa Hospital Research Institute

• 16:45 16:55

  Canadian Liver Meeting Opening Remarks

  Dr. Marc Bilodeau | Université de Montreal, Montreal, Canada

• 16:55 17:30

  CLM Opening Presentation ‑ Update on HCV Elimination in Canada and the US

  Dr. Andrew Aronsohn | University of Chicago 

• 17:30 19:30

  Joint CanHepC and Canadian Liver Meeting Reception and CanHepC Poster Viewing